Currently, it is widely accepted that COX-2 is overexpressed in some human RCC cell lines and plays a key role in the carcinogenesis of human RCC by promoting PGE2 production and inhibiting apoptosis to subsequently enhance tumorigenesis and angiogenesis in vivo (Chen et al., 2004). Here, PTGS2 is linked to renal cell adenocarcinoma.